Identification of fusion genes in breast cancer by paired-end RNA-sequencingHenrik Edgren, Olli Kallioniemi|Genome biology|2011Cited by 328
Association of tamoxifen resistance and lipid reprogramming in breast cancerSusanne Hultsch, Olli Kallioniemi|BMC Cancer|2018Cited by 217
The HER2 amplicon includes several genes required for the growth and survival of HER2 positive breast cancer cellsKristine Kleivi Sahlberg, Olli Kallioniemi|Molecular Oncology|2012Cited by 93
A cell spot microarray method for production of high density siRNA transfection microarraysJuha Rantala, Olli Kallioniemi|BMC Genomics|2011Cited by 58
Drug response profiles in patient-derived cancer cells across histological subtypes of ovarian cancer: real-time therapy tailoring for a patient with low-grade serous carcinomaAstrid Murumägi, Olli Kallioniemi|British Journal of Cancer|2022Cited by 25